The reading room
Evidence notes and provider dossiers
Read the denominator, the study design and the limits of the claim.
01Provider dossier
Best GLP-1 providers: what the evidence can tell you
A six-option starting list, with the boundary between an advertised service and demonstrated outcomes made explicit.
Read the note ↗02Evidence note 01A 20% lower hazard is not a 20-point difference
Reading the SELECT cardiovascular trial without confusing a relative measure, an observed proportion and a personal forecast.
Read the note ↗03Evidence note 02Why a safety-report count is not an event rate
Reports can reveal important signals without providing a denominator, a causal verdict or a fair ranking of medicines.
Read the note ↗04Evidence note 03When a study result becomes a marketing claim
Follow the chain from the original research to the product, population and service being advertised.
Read the note ↗